Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remote ECG Monitoring as a Diagnostic Tool for Therapeutic Strategies After Transcatheter Aortic Valve Replacement: Rationale and Design of the DRAGON-TAVI Trial.

NCT07521800 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.

NCT NCT07521800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07521800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remote ECG Monitoring as a Diagnostic Tool for Therapeutic Strategies After Transcatheter Aortic Valve Replacement: Rationale and Design of the DRAGON-TAVI Trial.
Lead sponsor
Medical University of Silesia
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2023
Completion date
February 1, 2028
Enrollment
250 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

arrythmia, atrial fibrillation (af), atrioventricular block, remote monitoring, tavi(transcatheter aortic valve implantation)